Sanofi's CEO exit highlights the brutal reality: patent cliffs demand proactive, successful...

Sanofi's CEO exit highlights the brutal reality: patent cliffs demand proactive, successful innovation or M&A. Stalled R&D and ineffective bolt-ons directly led to leadership change.

This underscores the intense pressure on pharma to build a future-proof pipeline, a critical lesson for Indian companies navigating global competition.

https://pharma.economictimes.indiatimes.com/news/pharma-industry/sanofi-ousts-ceo-hudson-after-stalled-turnaround-at-vaccine-giant/128252779